Mesa Laboratories, Inc.
MLAB
$71.62
-$2.32-3.14%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.39% | 8.33% | 11.47% | 11.68% | 6.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.39% | 8.33% | 11.47% | 11.68% | 6.88% |
| Cost of Revenue | 11.48% | 10.86% | 8.77% | 3.97% | -1.39% |
| Gross Profit | 5.04% | 6.86% | 13.10% | 16.61% | 12.27% |
| SG&A Expenses | 5.10% | 5.01% | 3.16% | 0.19% | 4.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.76% | 7.08% | 5.13% | 1.89% | 1.50% |
| Operating Income | 2.07% | 33.29% | 376.48% | 7,609.85% | 361.06% |
| Income Before Tax | 102.73% | 103.35% | 102.16% | -45,402.87% | -42,543.50% |
| Income Tax Expenses | 144.10% | 147.27% | 137.08% | -1,223.10% | -21,395.74% |
| Earnings from Continuing Operations | 99.36% | 99.75% | 99.22% | -26,412.55% | -34,160.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 99.36% | 99.75% | 99.22% | -26,412.55% | -34,160.95% |
| EBIT | 2.07% | 33.29% | 376.48% | 7,609.85% | 361.06% |
| EBITDA | -4.26% | -0.81% | 19.38% | 31.56% | 14.40% |
| EPS Basic | 99.34% | 99.75% | 99.25% | -26,360.65% | -34,455.31% |
| Normalized Basic EPS | -15.32% | 231.40% | 3,855.56% | 811.49% | 1,478.39% |
| EPS Diluted | 99.30% | 99.70% | 99.22% | -27,716.36% | -31,870.11% |
| Normalized Diluted EPS | -16.17% | 227.03% | 3,836.80% | 803.45% | 1,455.94% |
| Average Basic Shares Outstanding | 1.15% | 0.81% | 0.61% | 0.61% | 0.70% |
| Average Diluted Shares Outstanding | 1.25% | 1.35% | 0.99% | 0.85% | 0.86% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -157.03% | -405.88% | -128.58% | -1.00% | 1.00% |